Wave Life Sciences (WVE) Revenue Growth (3y) (2018 - 2026)
Wave Life Sciences (WVE) Revenue Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 54.05% |
| 10 | Wave Life Sciences | 1.18 Bn | 635.40 Mn | - | 43.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.55% |
| Jun 30, 2025 | 185.20% |
| Mar 31, 2025 | 73.72% |
| Jun 30, 2024 | 92.14% |
| Dec 31, 2023 | 45.47% |
| Sep 30, 2023 | 142.53% |
| Jun 30, 2023 | 94.01% |
| Mar 31, 2023 | 45.92% |
| Dec 31, 2022 | -19.78% |
| Sep 30, 2022 | -54.01% |
| Jun 30, 2022 | -63.37% |
| Mar 31, 2022 | -16.69% |
| Dec 31, 2021 | -21.29% |
| Sep 30, 2021 | 100.88% |
| Jun 30, 2021 | -17.14% |
| Dec 31, 2020 | 104.85% |
| Sep 30, 2020 | 37.92% |
| Jun 30, 2020 | 40.26% |
| Mar 31, 2020 | 121.48% |
| Dec 31, 2019 | 52.55% |